Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...

GLP-1 receptor agonists are everywhere and everybody is talking about them. Most of the orthopaedic discussions have been around when to stop them before surgery. That matters, but much more is being ...

Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.

Lexaria Bioscience Corporation (NASDAQ:LEXX) announced results from its Phase Ib study evaluating multiple GLP-1 agonists in combination with DehydraTECH (DHT). The study met its primary endpoint with ...

Genes may predict GLP-1 weight loss, linking genetic variants to treatment response and side effects in 27,885 patients using GLP-1 drugs.

Find out more about the association between GLP-1 use in patients with Type 2 diabetes and erectile dysfunction.

Emerging evidence suggests that microbial metabolites not only regulate endogenous GLP-1 secretion but may also influence therapeutic response to GLP-1 receptor agonists, raising the prospect of ...

Semaglutide and tirzepatide telehealth access, compounded GLP-1 program pricing, refund terms, and weight loss medication ...

The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the ...

From laboratory models to small human trials, a new review explores whether popular metabolic drugs could help curb alcohol, nicotine, and drug use, while underscoring how much clinical testing still ...